265 related articles for article (PubMed ID: 32502458)
1. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Erker C; Tamrazi B; Poussaint TY; Mueller S; Mata-Mbemba D; Franceschi E; Brandes AA; Rao A; Haworth KB; Wen PY; Goldman S; Vezina G; MacDonald TJ; Dunkel IJ; Morgan PS; Jaspan T; Prados MD; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e317-e329. PubMed ID: 32502458
[TBL] [Abstract][Full Text] [Related]
2. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
[TBL] [Abstract][Full Text] [Related]
3. Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Cooney TM; Cohen KJ; Guimaraes CV; Dhall G; Leach J; Massimino M; Erbetta A; Chiapparini L; Malbari F; Kramer K; Pollack IF; Baxter P; Laughlin S; Patay Z; Young Poussaint T; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e330-e336. PubMed ID: 32502459
[TBL] [Abstract][Full Text] [Related]
4. Review of imaging recommendations from Response Assessment in Pediatric Neuro-Oncology (RAPNO).
Bhatia A; Sabin ND; Fisher MJ; Poussaint TY
Pediatr Radiol; 2023 Dec; 53(13):2723-2741. PubMed ID: 37864711
[TBL] [Abstract][Full Text] [Related]
5. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
[TBL] [Abstract][Full Text] [Related]
6. Response Assessment in Neuro-Oncology Clinical Trials.
Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
[TBL] [Abstract][Full Text] [Related]
7. Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.
Braunstein S; Raleigh D; Bindra R; Mueller S; Haas-Kogan D
J Neurooncol; 2017 Sep; 134(3):541-549. PubMed ID: 28357536
[TBL] [Abstract][Full Text] [Related]
8. Arterial spin labelling and diffusion-weighted imaging in paediatric brain tumours.
Hales PW; d'Arco F; Cooper J; Pfeuffer J; Hargrave D; Mankad K; Clark C
Neuroimage Clin; 2019; 22():101696. PubMed ID: 30735859
[TBL] [Abstract][Full Text] [Related]
9. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [
Piccardo A; Albert NL; Borgwardt L; Fahey FH; Hargrave D; Galldiks N; Jehanno N; Kurch L; Law I; Lim R; Lopci E; Marner L; Morana G; Young Poussaint T; Seghers VJ; Shulkin BL; Warren KE; Traub-Weidinger T; Zucchetta P
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3852-3869. PubMed ID: 35536420
[TBL] [Abstract][Full Text] [Related]
10. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group.
Warren KE; Poussaint TY; Vezina G; Hargrave D; Packer RJ; Goldman S; Wen PY; Pollack IF; Zurakowski D; Kun LE; Prados MD; Rutkowski S; Kieran MW
Pediatr Blood Cancer; 2013 Sep; 60(9):1397-401. PubMed ID: 23625747
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in radiologic assessment of pediatric brain tumors during treatment, part 1.
D'Arco F; Culleton S; De Cocker LJL; Mankad K; Davila J; Tamrazi B
Pediatr Radiol; 2018 Dec; 48(13):1833-1843. PubMed ID: 29980859
[TBL] [Abstract][Full Text] [Related]
12. Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.
Inano R; Oishi N; Kunieda T; Arakawa Y; Yamao Y; Shibata S; Kikuchi T; Fukuyama H; Miyamoto S
Neuroimage Clin; 2014; 5():396-407. PubMed ID: 25180159
[TBL] [Abstract][Full Text] [Related]
13. Evolving management of low grade glioma: No consensus amongst treating clinicians.
Field KM; Rosenthal MA; Khasraw M; Sawkins K; Nowak AK
J Clin Neurosci; 2016 Jan; 23():81-87. PubMed ID: 26601811
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
[TBL] [Abstract][Full Text] [Related]
15. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J; Onar-Thomas A; Young Poussaint T; Wu S; Ligon AH; Lindeman N; Banerjee A; Packer RJ; Kilburn LB; Goldman S; Pollack IF; Qaddoumi I; Jakacki RI; Fisher PG; Dhall G; Baxter P; Kreissman SG; Stewart CF; Jones DTW; Pfister SM; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
Lancet Oncol; 2019 Jul; 20(7):1011-1022. PubMed ID: 31151904
[TBL] [Abstract][Full Text] [Related]
16. Classification of High-Grade Glioma into Tumor and Nontumor Components Using Support Vector Machine.
Blumenthal DT; Artzi M; Liberman G; Bokstein F; Aizenstein O; Ben Bashat D
AJNR Am J Neuroradiol; 2017 May; 38(5):908-914. PubMed ID: 28385884
[TBL] [Abstract][Full Text] [Related]
17. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Wen PY; Macdonald DR; Reardon DA; Cloughesy TF; Sorensen AG; Galanis E; Degroot J; Wick W; Gilbert MR; Lassman AB; Tsien C; Mikkelsen T; Wong ET; Chamberlain MC; Stupp R; Lamborn KR; Vogelbaum MA; van den Bent MJ; Chang SM
J Clin Oncol; 2010 Apr; 28(11):1963-72. PubMed ID: 20231676
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.
Peng J; Zhou H; Tang O; Chang K; Wang P; Zeng X; Shen Q; Wu J; Xiao Y; Patel SH; Hu C; Jin K; Xiao B; Boxerman J; Gao X; Wen PY; Bai HX; Huang RY; Yang L
Neuro Oncol; 2020 Oct; 22(10):1536-1544. PubMed ID: 32215549
[TBL] [Abstract][Full Text] [Related]
19. Pros and cons of current brain tumor imaging.
Ellingson BM; Wen PY; van den Bent MJ; Cloughesy TF
Neuro Oncol; 2014 Oct; 16 Suppl 7(Suppl 7):vii2-11. PubMed ID: 25313235
[TBL] [Abstract][Full Text] [Related]
20. Response assessment in neuro-oncology.
Quant EC; Wen PY
Curr Oncol Rep; 2011 Feb; 13(1):50-6. PubMed ID: 21086192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
